Peptide procurement resources

When peptide HPLC results differ: reviewing method comparability

Before treating two HPLC purity numbers as a trend, compare the sample, reported attribute, method revision and reporting basis behind each result.

Hytanbio Editorial TeamPublished 4 minute read

Two document folders beside the exterior of an analytical chromatography instrument

Two peptide HPLC percentages need a comparability review before they are treated as evidence that quality improved or declined. Check whether the reports cover the same material, sample state, analytical attribute and method revision. Put unexplained differences to the responsible laboratory before changing the purchasing specification.

Start with the attribute being reported

A chromatographic purity percentage, an assay against a reference and an identity finding answer different questions. Ask which attribute each report measures and how the result is expressed. Record units and calculation basis exactly as supplied. A field labeled “purity” on two certificates may still require clarification before its values can be compared.

Bachem’s quality-control guide discusses purity and other product-content measurements as separate parts of peptide characterization. That supports keeping water, counter-ion content and related results in their own fields rather than reading them into an HPLC percentage. Source: Bachem quality-control guide.

Identify the question behind an LC-MS attachment

If a supplier also provides a mass-spectrometry report, ask which identity claim it supports and whether its sample reference matches the HPLC report. The presence of an attachment should not cause the buyer to mark an unrelated content or impurity requirement as complete. Let the laboratory state the conclusions supported by its methods.

Use a report comparison sheet

Fields to compare before interpreting a difference
Field Document question
Material and chemical form Do both records describe the same requested identity and supplied form?
Lot and sample reference Are these repeat measurements, different samples from one lot, or different lots?
Method identifier Which controlled method and revision produced each result?
Reported attribute Do both percentages refer to the same analytical quantity?
Reporting and integration basis Does the laboratory consider the reported values directly comparable?
Acceptance criterion Which agreed specification version was used for each conclusion?

This is a document review, not an instruction to reproduce a laboratory procedure. A buyer can record method references and request the laboratory’s assessment without prescribing instrument settings or changing a validated procedure.

Ask for the evidence behind a method change

ICH Q2(R2), section 2.2, addresses changes during an analytical procedure’s lifecycle and ties the extent of revalidation to the performance characteristics affected. It also discusses transfer between laboratories. This pharmaceutical guideline is cited here as a reference for asking about analytical evidence; it does not establish that a research-use supplier or cosmetic material has regulatory approval. Source: ICH Q2(R2), section 2.2.

For a commercial change review, request the old and new method identifiers, the reason for the change and the laboratory’s conclusion about comparability. If supporting work was performed, ask for its scope and approved summary. Keep any limitation attached to the conclusion. A statement covering one material or attribute should not be extended to every product in the catalog.

Do not average incompatible results

Imagine a buyer receives two illustrative purity results, 98.4% and 99.1%, from different method revisions. Their arithmetic average is 98.75%, but that number has no agreed purchasing meaning until the methods, samples and reporting bases are understood. Preserve the two original values and the laboratory’s explanation. These figures are invented solely to demonstrate a review error.

Close the purchasing question explicitly

  • If the methods are comparable, retain the laboratory’s justification with the reports.
  • If they measure different attributes, separate those attributes in the specification.
  • If the difference remains unexplained, keep the lot review open and assign the question to the responsible reviewer.
  • If a revised specification is agreed, record its effective version and the lots to which it applies.

A new method identifier is not automatically a product failure. Equally, a higher reported percentage is not enough to dismiss a documented change. The purchasing decision needs a stated acceptance basis that the supplier and buyer can both retrieve later.

Attach both reports when requesting analytical document review. State the commercial decision you need to make, such as whether an allocated lot meets an agreed specification. The specification change guide covers the approval record for changing that agreement.

Frequently asked questions

Can HPLC results from different laboratories be compared?

They may be comparable, but the sample references, measured attribute, methods and reporting bases need review. Ask the laboratories for the evidence supporting the comparison.

Does a higher HPLC purity result prove a better lot?

It does not settle that purchasing decision by itself. First establish comparability and assess the result against the agreed specification and other required attributes.

Should I average two different reported purity results?

Preserve each result with its method and sample reference. Averaging is inappropriate unless a qualified review establishes a valid reason and reporting basis for doing so.

Does citing ICH Q2(R2) mean the supplier is approved?

No. The citation identifies an analytical reference framework. It is not a statement of supplier certification, product approval or suitability for human use.

References

  1. ICH: Q2(R2), Validation of Analytical Procedures, section 2.2
  2. Bachem: quality-control guide

Source pages checked on 31 October 2026. Procurement examples are editorial illustrations; they are not batch results or company certification claims.

Editorial scope: B2B material identity, document review and procurement. Research-only materials retain their stated restrictions. Product specifications and available documents require confirmation for the proposed lot and project.

SEND A SPEC-FIRST BULK ENQUIRY

Start with identity, quantity,
packaging and documents.

Send bulk RFQ ↗
WhatsApp